Discontinuation report CYTARABINE INJECTION

Last updated on 2019-09-25 History
Report ID 94589
Drug Identification Number 02126656
Brand name CYTARABINE INJECTION
Common or Proper name CYTARABINE INJECTION
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) CYTARABINE
Strength(s) 100MG
Dosage form(s) SOLUTION
Route of administration INTRATHECAL INTRAVENOUS SUBCUTANEOUS
Packaging size 10mL vial
ATC code L01BC
ATC description ANTIMETABOLITES
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2019-09-24
Remaining supply date 2019-09-24
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments 1mL and 20mL presentations remain available.
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2019-09-25 English Compare
v2 2019-09-24 French Compare
v1 2019-09-24 English Compare

Showing 1 to 3 of 3